Melanoma Clinical Trial

Clinical Trial Finder Melanoma Trials

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

See Locations Near You

Summary

This study evaluated the pharmacokinetics of aldesleukin in participants with metastatic renal cell cancer or metastatic melanoma.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria:

Performance Status Eastern Cooperative Oncology Group: 0 or 1.
Adequate organ function.

Exclusion criteria:

Pregnancy or lactation.
Prior treatment with any form of IL-2.
Organ transplant. Other protocol-defined inclusion/exclusion criteria may apply

Study is for people with:

Melanoma

Phase:

Phase 4

Estimated Enrollment:

26

Study ID:

NCT00414765

Recruitment Status:

Completed

Sponsor:

Novartis Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

USC/Kenneth Norris Comprehensive Cancer Center
Los Angeles California, 90033, United States
University of Colorado Cancer Center
Aurora Colorado, 80045, United States
James Graham Brown Cancer Center
Louisville Kentucky, 40202, United States
Dartmouth Hitchcock Medical Center
Lebanon New Hampshire, 03756, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Phase:

Phase 4

Estimated Enrollment:

26

Study ID:

NCT00414765

Recruitment Status:

Completed

Sponsor:


Novartis Pharmaceuticals

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider